CSX Corporation vs Medpace Holdings Inc — how do they compare? CSX Corporation trades at $50.06 (market cap $92.55B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: CSX Corporation is far larger — about 5.5× Medpace Holdings Inc's market cap, and CSX Corporation pays a 1.12% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| CSX | MEDP | |
|---|---|---|
Market Cap | $92.55B | $16.90B |
Sector | Industrials | Technology |
52-Week High | $53.21 | $620.59 |
52-Week Low | $32.05 | $393.42 |
Enterprise Value | $110.52B | $16.52B |
Dividend Yield | 1.12% | — |
Trailing returns across standard periods
Latest headlines on both assets
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →